Skip to main content
Premium Trial:

Request an Annual Quote

Larry Greller, Frank Chiu, Anthony Carrano


Larry Greller, formerly assistant director of bioinformatics mathematical biology at SmithKline Beecham Pharmaceuticals, has been named director of mathematical biology and systems modeling at Molecular Mining of Kingston, Ontario.

Greller received his PhD in mathematical molecular biology from the University of Pennsylvania, an MS in computer and information science from Penn’s Moore School of Electrical Engineering, and a BS in Physics from Drexel University.

NeoTherapeutics has hired Frank Chiu as director, biostatistics and data management.

Chiu will direct efficacy and safety analyses for the company’s upcoming clinical studies of Neotrofin in Alzheimer’s disease, Parkinson’s disease, and spinal cord injury. He will also manage data and develop statistical analysis plans for regulatory filings.

Previously, Chiu held a number of positions in biostatistics and data management at Ligand Pharmaceuticals and Allergan. He has been involved in data management and statistical analysis for two drugs that were approved by the US FDA and are now on the market.

Odyssey Pharmaceuticals has appointed Anthony Carrano as acting director of research.

In his previous post as associate director of Lawrence Livermore National Laboratory, Carrano spearheaded the Human Genome Project for the Department of Energy. Under his direction, the Human Genome Center built a detailed physical map for chromosome 19, discovered numerous genes linked to human diseases, and established programs in functional genomics and computational biology to integrate structural, bioinformatics, and biochemical methods to understand protein function.

Carrano was president of the Human Genome Organization Americas from 1996 to 1999 and a US trustee of HUGO from 1994 to 2000.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more